Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pueraria thomsonii is a species of the Pueraria genus, which is primarily used in traditional Chinese medicine and as an edible food source. It's closely related to Pueraria lobata (kudzu), but has distinct chemical compositions and uses. ## Botanical and Medicinal Profile Pueraria thomsonii is rich in bioactive compounds, particularly flavonoids and isoflavonoids. Compared to Pueraria lobata, it contains higher starch content but lower levels of soluble dietary fiber, insoluble dietary fiber, and crude protein[2][6]. This composition makes it better suited as an edible food, while P. lobata is more appropriate for medicinal applications[2]. The root of Pueraria thomsonii is used in herbal products, similar to other Pueraria species[7]. It contains various bioactive compounds including puerarin, daidzein, genistein, quercetin, and other flavonoids that contribute to its pharmacological properties. ## Traditional Uses Pueraria species have been used in traditional Chinese medicine for centuries. They are employed to treat various conditions including: - Cardiovascular and cerebrovascular diseases - High cholesterol (hypolipidemia) - High blood sugar (hyperglycemia) - High blood pressure - Cancer (inhibiting cancer cell activity) - Improving brain blood flow and oxygen supply[2][6] ## Pharmacological Properties While many studies focus on Pueraria species collectively, specific research on P. thomsonii indicates it has potential applications in: - Antioxidant activity - Metabolic regulation - Nutritional supplementation The root is available in various commercial forms including capsules, tablets, creams, gels, and soaps[5]. ## Safety Considerations As with other Pueraria species, P. thomsonii should be used with caution due to its phytoestrogen-like effects. It may interact with: - Estrogen medications - Blood-clotting medications - Methotrexate - Tamoxifen - Hepatotoxic drugs - Caffeine[3][5] It should be avoided during pregnancy and lactation due to lack of clinical data and its phytoestrogen activity[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pueraria thomsonii.